New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
09:10 EDTQCORQuestcor's Acthar shows positive results for systemic lupus erythematosus
Questcor announced that results from the first modern clinical study examining the use of H.P. Acthar Gel in systemic lupus erythematosus has been published in the journal LUPUS. The results reveal that Acthar treatment resulted in significant improvements in certain clinical outcome measures that indicate a reduction of lupus disease activity. The drug was generally well-tolerated during the course of the study.
News For QCOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for QCOR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use